Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
DR Wang, XL Wu, YL Sun - Signal transduction and targeted therapy, 2022 - nature.com
Cancers are highly complex diseases that are characterized by not only the overgrowth of
malignant cells but also an altered immune response. The inhibition and reprogramming of …
malignant cells but also an altered immune response. The inhibition and reprogramming of …
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
RR Ramjiawan, AW Griffioen, DG Duda - Angiogenesis, 2017 - Springer
Angiogenesis is defined as the formation of new blood vessels from preexisting vessels and
has been characterized as an essential process for tumor cell proliferation and viability. This …
has been characterized as an essential process for tumor cell proliferation and viability. This …
COVID-19 vaccines: an overview of different platforms
D Kudlay, A Svistunov - Bioengineering, 2022 - mdpi.com
Vaccination is one of the key strategies to stop the COVID-19 pandemic. This review aims to
evaluate the current state of vaccine development and to determine the issues that merit …
evaluate the current state of vaccine development and to determine the issues that merit …
[HTML][HTML] Nanobody-based delivery systems for diagnosis and targeted tumor therapy
Y Hu, C Liu, S Muyldermans - Frontiers in immunology, 2017 - frontiersin.org
The development of innovative targeted therapeutic approaches are expected to surpass the
efficacy of current forms of treatments and cause less damage to healthy cells surrounding …
efficacy of current forms of treatments and cause less damage to healthy cells surrounding …
Vaccine candidates against coronavirus infections. Where does COVID-19 stand?
J Al-Kassmy, J Pedersen, G Kobinger - Viruses, 2020 - mdpi.com
Seven years after the Middle East respiratory syndrome (MERS) outbreak, a new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) made its first appearance in a food …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) made its first appearance in a food …
[HTML][HTML] Theranostics in immuno-oncology using nanobody derivatives
Q Lecocq, Y De Vlaeminck, H Hanssens… - Theranostics, 2019 - ncbi.nlm.nih.gov
Targeted therapy and immunotherapy have become mainstream in cancer treatment.
However, only patient subsets benefit from these expensive therapies, and often responses …
However, only patient subsets benefit from these expensive therapies, and often responses …
Mannose in vaccine delivery
Adjuvants and vaccine delivery systems are used widely to improve the efficacy of vaccines.
Their primary roles are to protect antigen from degradation and allow its delivery and uptake …
Their primary roles are to protect antigen from degradation and allow its delivery and uptake …
Nanoparticle-based delivery strategies of multifaceted immunomodulatory RNA for cancer immunotherapy
YJ Yoo, CH Lee, SH Park, YT Lim - Journal of Controlled Release, 2022 - Elsevier
Although cancer immunotherapy has emerged as a novel cancer treatment modality, it still
suffers from low therapeutic efficacy in clinics due to the presence of a low number of …
suffers from low therapeutic efficacy in clinics due to the presence of a low number of …
Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells
S Van Lint, D Renmans, K Broos, L Goethals… - Cancer immunology …, 2016 - AACR
Modulating the activity of tumor-infiltrating dendritic cells (TiDC) provides opportunities for
novel cancer interventions. In this article, we report on our study of the uptake of mRNA by …
novel cancer interventions. In this article, we report on our study of the uptake of mRNA by …
Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy
Y Lu, Y Shi, J You - Journal of Controlled Release, 2022 - Elsevier
The cross presentation of exogenous antigen (Ag) by dendritic cells (DCs) facilitates a
diversified mode of T-cell activation, orchestrates specific humoral and cellular immunity …
diversified mode of T-cell activation, orchestrates specific humoral and cellular immunity …